REG - Genedrive PLC - Block listing Interim Review

GenedriveAnnouncement

27/05/2022 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220527:nRSa9607Ma&default-theme=true

RNS Number : 9607M  Genedrive PLC  27 May 2022

 

 

genedrive plc

("genedrive" or the "Company")

 

Block Listing Six Monthly Return

 

 Name of applicant                                                               genedrive plc

 Name of scheme                                                                  2007 Share Option Scheme

 Period of return:                       From:                                   30 November 2021  To:         27 May 2022
 Balance of unallocated securities under scheme(s) from previous return:         146,726 shares
 Plus: The amount by which the block scheme(s) has been increased since the      Nil
 date of the last return (if any increase has been applied for):
 Less:  Number of securities issued/allotted under scheme(s) during period       7,500
 (see LR3.5.7G):
 Equals:  Balance under scheme(s) not yet issued/allotted at end of period:      139,226 shares

 

 

 Name of contact:              Russell Shaw CFO
 Telephone number of contact:  +44 (0)161 989 0245

 

For enquires:

 

 genedrive plc                                                                            +44 (0)161 989 0245
 David Budd: CEO / Russ Shaw: CFO

 Peel Hunt LLP (Nominated Adviser and Joint Broker)                                       +44 (0)20 7418 8900
 James Steel

 finnCap (Joint Broker)                                                                   +44 (0)20 7220 500
 Geoff Nash / Kate Bannatyne / Alice Lane

 Walbrook PR Ltd (Media Relations & Investor Relations)       +44 (0)20 7933 8780 or genedrive@walbrookpr.com
                                                              (mailto:genedrive@walbrookpr.com)
 Paul McManus / Anna Dunphy                                                               +44 (0)7980 541 893 / +44 (0)7876 741 001

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BLRUNVARUSUVUAR